NuGen Medical Devices Inc (TSE:NGMD) has released an update.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
NuGen Medical Devices Inc. has announced a strategic partnership with EziAutoJector Limited to distribute its needle-free InsuJet devices for delivering U-100 insulin and other subcutaneous biosimilar products in the UK and Germany. This collaboration is expected to generate significant revenue and enhance the distribution of NuGen’s innovative drug-device combination products. The partnership aims to address the unmet need for needle-free drug delivery and expand NuGen’s market presence in managing conditions like diabetes and weight loss.
For further insights into TSE:NGMD stock, check out TipRanks’ Stock Analysis page.